What does ARYSTA LIFESCIENCE BENELUX do?

ARYSTA LIFESCIENCE BENELUX is registered with the CBE as active in: Groothandel in chemische producten. Private Limited, started on 23 November 2005, 1 establishment.

What is the address of ARYSTA LIFESCIENCE BENELUX?

The registered office of ARYSTA LIFESCIENCE BENELUX is located at Rue de Renory 26 box 1, 4102 Seraing.

Is ARYSTA LIFESCIENCE BENELUX still active?

Yes. According to the CBE (30 October 2026) ARYSTA LIFESCIENCE BENELUX is active, legal situation “Normale toestand”, started on 23 November 2005.

Is ARYSTA LIFESCIENCE BENELUX registered on Peppol?

Yes, ARYSTA LIFESCIENCE BENELUX is registered on the Peppol network with ID 0208:0877444281.

What is the enterprise number of ARYSTA LIFESCIENCE BENELUX?

The enterprise number of ARYSTA LIFESCIENCE BENELUX is BE0877444281.

When was ARYSTA LIFESCIENCE BENELUX founded?

ARYSTA LIFESCIENCE BENELUX was founded on 23 November 2005.

Who are the directors of ARYSTA LIFESCIENCE BENELUX?

According to the 2025 annual accounts, the directors of ARYSTA LIFESCIENCE BENELUX are: Mandar Jayant KADAM, Guilhem LAFAIGE DE GAILLARD.

Is ARYSTA LIFESCIENCE BENELUX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 November 2005; 3 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did ARYSTA LIFESCIENCE BENELUX make in 2025?

ARYSTA LIFESCIENCE BENELUX posted a profit after taxes of € 8,135,842 in financial year 2025.

What is the revenue of ARYSTA LIFESCIENCE BENELUX?

In its most recent annual accounts (2025), ARYSTA LIFESCIENCE BENELUX reported revenue of € 118,422,398.

How much does an employee at ARYSTA LIFESCIENCE BENELUX earn?

The average wage cost per full-time employee at ARYSTA LIFESCIENCE BENELUX was € 119,400 in 2025: staff costs of € 4.6 million for 38.2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ARYSTA LIFESCIENCE BENELUX have?

According to the 2025 annual accounts, ARYSTA LIFESCIENCE BENELUX has 38.2 full-time equivalents (FTE).

ARYSTA LIFESCIENCE BENELUX (Private Limited) - Seraing

Dossier ARYSTA LIFESCIENCE BENELUX, printed on 30 October 2026 from databakkes.be/en/0877444281/arysta-lifescience-benelux. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ARYSTA LIFESCIENCE BENELUX from Seraing, company number BE0877444281, closed financial year 2025 with a result of € 8.1 million after tax. For that financial year ARYSTA LIFESCIENCE BENELUX recorded revenue of € 118.4 million and equity of € 158.3 million. Compared with financial year 2023, the result moved from € 25.6 million to € 8.1 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.

What it is worth Growing

€ 158.3 million

▲ 14% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 8.1 million

▼ 68% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 457,108

▲ 7% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 146.1 million.

People and assets in 2025

Full-time equivalents

38.2

▼ 1.3 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost Staff costs are payroll only. Director pay sits with services and miscellaneous goods: € 5.5 million in 2025, together with rent, insurance, accountants and other services. The accounts do not split that further.

€ 4.6 million

▼ 1% vs 2023

€ 119,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,766

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 29.3 million

▼ 39% vs 2023

Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 105 days on average.

Taxes and wages

€ 5.5 million

▼ 51% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2025	Change 2023 → 2025
Revenue	€ 194,874,662 Revenue 2022: € 194,874,662 First fiscal year in the series	€ 228,602,866 Revenue 2023: € 228,602,866 ▲ 17% vs 2022 (€ 194,874,662) Favourable step	€ 118,422,398 Revenue 2025: € 118,422,398 ▼ 48% vs 2023 (€ 228,602,866) Unfavourable step	▼ 48%
Profit after taxes	€ 20,755,033 Profit after taxes 2022: € 20,755,033 First fiscal year in the series	€ 25,557,663 Profit after taxes 2023: € 25,557,663 ▲ 23% vs 2022 (€ 20,755,033) Favourable step	€ 8,135,842 Profit after taxes 2025: € 8,135,842 ▼ 68% vs 2023 (€ 25,557,663) Unfavourable step	▼ 68%
Equity	€ 113,892,910 Equity 2022: € 113,892,910 First fiscal year in the series	€ 139,449,195 Equity 2023: € 139,449,195 ▲ 22% vs 2022 (€ 113,892,910) Favourable step	€ 158,305,389 Equity 2025: € 158,305,389 ▲ 14% vs 2023 (€ 139,449,195) Favourable step	▲ 14%
Total debts	€ 83,137,479 Total debts 2022: € 83,137,479 First fiscal year in the series	€ 59,828,214 Total debts 2023: € 59,828,214 ▼ 28% vs 2022 (€ 83,137,479) Favourable step	€ 34,799,772 Total debts 2025: € 34,799,772 ▼ 42% vs 2023 (€ 59,828,214) Favourable step	▼ 42%
Cash	€ 213,413 Cash 2022: € 213,413 First fiscal year in the series	€ 425,392 Cash 2023: € 425,392 ▲ 99% vs 2022 (€ 213,413) Favourable step	€ 457,108 Cash 2025: € 457,108 ▲ 7% vs 2023 (€ 425,392) Favourable step	▲ 7%
Retained profit	€ 101,666,438 Retained profit 2022: € 101,666,438 First fiscal year in the series	€ 127,224,101 Retained profit 2023: € 127,224,101 ▲ 25% vs 2022 (€ 101,666,438) Favourable step	€ 146,083,061 Retained profit 2025: € 146,083,061 ▲ 15% vs 2023 (€ 127,224,101) Favourable step	▲ 15%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 621,222 Bank debt 2023: € 621,222 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2023 (€ 621,222) Favourable step	▼ 100%
Balance sheet total	€ 197,031,770 Balance sheet total 2022: € 197,031,770 First fiscal year in the series	€ 199,278,331 Balance sheet total 2023: € 199,278,331 ▲ 1% vs 2022 (€ 197,031,770) Unchanged	€ 193,105,161 Balance sheet total 2025: € 193,105,161 ▼ 3% vs 2023 (€ 199,278,331) Unchanged	▼ 3%
Employees (FTE)	38.9 Employees (FTE) 2022: 38.9 First fiscal year in the series	39.5 Employees (FTE) 2023: 39.5 ▲ 0.6 vs 2022 (38.9) Unchanged	38.2 Employees (FTE) 2025: 38.2 ▼ 1.3 vs 2023 (39.5) Unchanged	▼ 1.3

Key figures of ARYSTA LIFESCIENCE BENELUX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to ARYSTA LIFESCIENCE BENELUX?

What happened at ARYSTA LIFESCIENCE BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 31, 2025 New annual accounts for financial year 2025: profit of € 8.1 million (▼ 68% vs 2023). Source: NBB ↗
2019 Mandar Jayant KADAM became a director. NBB
2015 Guilhem LAFAIGE DE GAILLARD became a director. NBB
Nov 23, 2005 Start of the company according to the CBE. KBO
Oct 20, 2005 New establishment in Seraing. KBO

In short

From € 20.8 million profit in 2022 to € 8.1 million profit in 2025.

Paid € 18.2 million in corporate taxes since 2022.

Best year ever: 2023, with € 25.6 million profit.

Pays suppliers within 105 days on average.

Original PDFs at the National Bank ↗

Management

Mandar Jayant KADAM Guilhem LAFAIGE DE GAILLARD

Arysta LifeScience Ougrée Production

ARYSTA LIFESCIENCE BENELUX

Behind ARYSTA LIFESCIENCE BENELUX are Mandar Jayant KADAM and Guilhem LAFAIGE DE GAILLARD. Mandar Jayant KADAM is also behind Arysta LifeScience Ougrée Production.

Directors

According to the 2025 annual accounts

Mandar Jayant KADAM

Director

Also active at: Arysta LifeScience Ougrée Production

since 2019

Guilhem LAFAIGE DE GAILLARD

Director

since 2015

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Renory 26 box 1

4102 Seraing

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Arysta LifeScience Ougrée Production same network

€ 27.7 million revenue · 2026

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0877.444.281

VAT number

BE 0877.444.281

Registered office

Rue de Renory 26 bus 1, 4102 Seraing

Names & denominations

ARYSTA LIFESCIENCE BENELUX

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 November 2005

Peppol

Active · Active since 4 Jun 2026

Activities · NACE

Groothandel in chemische producten

Groothandel in chemische producten voor industrieel gebruik

Vervaardiging van verdelgingsmiddelen, ontsmettingsmiddelen en andere chemische producten voor de landbouw

Vervaardiging van verdelgingsmiddelen en van andere chemische producten voor de landbouw

View on CBE Public ↗ Annual accounts (NBB) ↗

ARYSTA LIFESCIENCE BENELUX

Financials

What happened to ARYSTA LIFESCIENCE BENELUX?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions